Peter Frampton - Inclusion Body Myositis
Updated: Sep 7, 2019
Grammy award-winning musician Peter Frampton has declared his 2019 51-city North American tour to be his final farewell to performing due to his diagnosis of Inclusion Body Myositis, an inflammatory muscle disease.
This episode considers how IBM presents itself and how it runs its course. It also examines why it targets certain body parts.
The guest who explores IBM in detail is Dr. Lisa Christopher-Stine, an associate professor of medicine and neurology at the Johns Hopkins University School of Medicine and the Director of the Johns Hopkins Myositis Center. She serves as one of the Johns Hopkins University School of Medicine College Advisors, and is a Board Member of the Johns Hopkins Institutional Review Board. She also serves as the Deputy Director of Telemedicine in the Division of Rheumatology.